Andrea Viecelli

A/Prof Andrea Viecelli is an academic nephrologist at Princess Alexandra Hospital in Brisbane, Australia and was awarded her PhD on strategies to improve vascular access outcomes in patients on haemodialysis in 2019 through the University of Queensland. As a clinical trialist of the Australasian Kidney Trials Network (AKTN) she plays a key role in designing and conducting international clinical trials in people with chronic kidney disease. As a Coordinating Committee member, Transplant Cardiovascular- and Haemodialysis Vascular Access Project Coordinator of the global SONG initiative, she is conducting clinical and qualitative research to establish standardised core outcome measures based on the shared priorities of >10000 patients, clinicians, researchers and policy makers from >100 countries to improve the relevance and reliability of kidney research to inform patient-centred care. As member of the International Society of Nephrology Young Nephrologists Committee (ISN YNC), chair of the ISN YNC capacity building Subcommittee, ISN Advancing Clinical Trials Committee, member of the ISN Advancing Clinical Trials committee and as ISN Global Kidney Health Atlas Project (GKHA) Fellow, she engages health professionals and consumers to promote equitable professional engagement, career development, trial conduct and participation and access to kidney care in Australia and internationally. She has received numerous local, national and international awards for her research, including the ANZSN Young Investigator Award (2017), Kidney Health Australia Clinical Research Award (2016), the ERA EDTA Young Investigator award (2017 and 2018) and the 2018 and 2022 Sylvan Green Award from the Society for Clinical Trials. As the recipient of a National Health and Medical Research Council (NHMRC) Emerging Leadership Investigator Grant and a Queensland Advancing Clinical Research Fellowship she currently pursues a program of clinical and qualitative research to improve patient-important outcomes in haemodialysis.